“Global Women’s Health Diagnostics Market” Top Key Companies Siemens AG , Quest Diagnostics Inc., Hologic, Inc., F. Hoffmann-La Roche AG, PerkinElmer Inc.

Global Women’s Health Diagnostics Market By Application (Osteoporosis Testing {Bone Densitometry, in Vitro Blood Tests}), Breast Cancer Testing {Mammography, Breast Cancer Tumor Marker Tests, Blood Chemistries and Blood Cell Count Tests, Biopsies}, Ovarian Cancer Test {Ovarian Cancer Tumor Marker Test, Diagnostic Imaging Test}, Cervical Cancer Test {PAP Smear, HPV Test}, Pregnancy and Fertility Test {Lab-Based Test, Pregnancy Testing and Ovulation Prediction Kits, Fertility Monitors}, Prenatal Genetic Screening and Carrier Test {Cystic Fibrosis, Down Syndrome and Edwards Syndrome, Torch Infections}, Infectious Disease Test {MRSA Test, Urinary Tract Infection Test, Hepatitis Test, Tuberculosis Test}, Sexually Transmitted Disease Test {Chlamydia Trachomatis and Neisseria Gonorrhoeae Test, HIV Test}, Ultrasound Test {Breast Imaging, Obstetrics or Gynecology Imaging}), By End User (Hospitals, Clinics, Diagnostic Laboratories), By Geography – Industry Trends and Forecast to 2024

Customize Report of “Global Women’s Health Diagnostics Market” Also Available On Request (As per Requirement)

Get a Free Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-womens-health-diagnostics-market

The Global Women’s Health Diagnostics Market accounted to USD 25.03 billion in 2016 growing at a CAGR of around 7.9% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

This report consists of below pages:
No of pages : 350 No of Figures: 60 No of Tables: 220

Market Definition:

Women’s health issues are increasing day by day. Diseases such as cancers of ovarian, cervical, breasts, infectious diseases such as HIV and hepatitis are prevalent nowadays in women. Rise in geriatric population and lifestyle disorders are the factors which drive the market whereas lack of skilled surgeons or physicians restrain the market.

Competitive Analysis:

The Global Women’s Health Diagnostics Market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global women’s health diagnostics market for global, Europe, North America, Asia Pacific and South America.

Questions? We’ll Put You On The Right Path Request Analyst Call @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-womens-health-diagnostics-market

Major Market Drivers:

• Rise in prevalence of infectious diseases in women.
• Risingin the number of chronic and lifestyle-related disorders in women.
• Initiatives taken by government and health organizations.
• Increased Adoption of Point-Of-Care and Rapid Diagnostic Tests
• High price of diagnostic imaging systems and procedures hampers the market.
• Lack skilled physicians or surgeons.
• Increased regulatory approvals for immunoassay diagnostic techniques.

Get a Detail TOC of Global Women’s Health Diagnostics Market @ http://databridgemarketresearch.com/toc/?dbmr=global-womens-health-diagnostics-market

Market Segmentation:

The Global Women’s Health Diagnostics Market is segmented by Application into Osteoporosis Testing, Breast Cancer Testing, Ovarian Cancer Test, Cervical Cancer Test, Pregnancy and Fertility Test, Prenatal Genetic Screening and Carrier Test, Infectious Disease Test, Sexually Transmitted Disease Test, Ultrasound Test.

Osteoporosis testing is further segmented into bone densitometry and In Vitro blood tests. Breast cancer testing is further segmented into mammography, breast cancer tumor marker tests, blood chemistries and blood cell count tests, biopsies and others. Ovarian cancer testing is further segmented into ovarian cancer tumor marker test, diagnostic imaging test and other tests.Cervical cancer test is further segmented into PAPsmear and HPV test.Pregnancy and fertility test is further segmented into lab-based test, pregnancy testing & ovulation prediction kits and fertility monitors.Prenatal Genetic Screening and Carrier Test arefurther segmented into cystic fibrosis, Down Syndrome and Edwards Syndrome, torch infections and other diseases.Infectious Disease Test is further segmented into MRSA Test, urinary tract infection test, hepatitis test, tuberculosis test and other tests.Sexually Transmitted Disease Test is further segmented into Chlamydia trachomatis or Neisseria gonorrhoeae (CT/NG testing), HIV Test and other STDs.

Ultrasound Test is further segmented into breast imaging, obstetrics or gynecology imaging.

By End User the market is segmented into hospitals, clinics and diagnostic laboratories.

On the basis of geography, global women’s health diagnostics market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, andBrazil among others. In 2017, North America is expected to dominate the market.

Avail 10% Discount on Industrial Robots Market Report@ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-womens-health-diagnostics-market

Major Market Competitors:

Some of the major players operating in Global women’s health diagnostics market are

• Siemens AG ,
• Quest Diagnostics Inc.,
• Hologic, Inc.,
• F. Hoffmann-La Roche AG,
• PerkinElmer Inc.,
• GE Company,
• BD,bioMérieux SA,
• Koninklijke Philips N.V.,
• DIALAB GmbH,
• Fujifilm Holdings Corporation,
• GE Company,
• GenMark Diagnostics, Inc.,
• Trinity Biotech,
• Luminex Corporation,
• Nova Biomedical,
• PerkinElmer Inc.,
• Toshiba Medical System Corporation,
• Carestream Health and Hitachi, Ltd.
• among others.

Read more about Global Women’s Health Diagnostics Market @ http://databridgemarketresearch.com/reports/global-womens-health-diagnostics-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog: http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

Data Bridge is an organization lead by well versed forecasters, analysts and researchers who indulge in detailed and diligent research on different markets, trends and emerging opportunities in the successive direction to cater to your business needs. Data Bridge aims to make your organization well acquainted with profound knowledge of the global and local market statistics.

Data Bridge Market Research
Office Number 402 & 317,
Amanora Chambers,
Magarpatta Road, Hadapsar
Pune – 411028
Maharashtra, India

This release was published on openPR.